
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Ticker | Name | Price | Change | Change % | Volume | Trades |
---|---|---|---|---|---|---|
![]() | Bowen Coking Coal Limited | 0.3175 | 0.3135 | 7,837.50% | 794,455 | 69 |
![]() | Hydrocarbon Dynamics Limited | 0.003 | 0.001 | 50.00% | 3,038,301 | 7 |
![]() | Traffic Technologies Ltd | 0.003 | 0.001 | 50.00% | 1,630,346 | 4 |
![]() | Hastings Technology Metals Limited | 0.06 | 0.018 | 42.86% | 21,878 | 5 |
![]() | VHM Ltd | 0.3375 | 0.0975 | 40.63% | 540,915 | 84 |
![]() | Advance Metals Ltd | 0.048 | 0.013 | 37.14% | 53,478,891 | 762 |
![]() | Australian Strategic Materials Limited | 0.10 | 0.026 | 35.14% | 60,952 | 8 |
![]() | Seafarms Group Limited | 0.002 | 0.0005 | 33.33% | 172,883 | 1 |
![]() | Duxton Water Limited | 0.004 | 0.001 | 33.33% | 741 | 1 |
![]() | Adavale Resources Limited | 0.002 | 0.0005 | 33.33% | 640,000 | 4 |
![]() | Southern Hemisphere Mining Limited | 0.04 | 0.01 | 33.33% | 5,582,258 | 94 |
Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (“Adagio” or “the Company”), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that it has received Breakthrough Device designation from the U.S. Food and Drug Administration (“FDA”) for its vCLASTM Cryoablation System for the treatment of drug-refractory, recurrent, sustained monomorphic ventricular tachycardia (“VT”) in patients with ischemic or non-ischemic structural heart disease. Adagio’s vCLASTM Cryoablation System, which is currently the subject of an Investigational Device Exemption (“IDE”) study called FULCRUM-VT, is a purpose-built system using the Company’s proprietary Ultra-Low Temperature Cryoablation (“ULTC”) technology and is designed to ...
BEIJING, April 18, 2025 /PRNewswire/ -- Baijiayun Group Ltd ("Baijiayun" or the "Company") (NASDAQ: RTC), a one-stop AI video solution provider, today announced that it held a Spring Health Run event with the theme of "Chasing Light in the Green Fields • Setting Sail towards Health" at its Beijing office on April 17th. The competition was divided into two groups: the men's group challenged a 6-kilometer run around the park for three laps, while the women's group had a 4-kilometer race for two laps. More than twenty employee athletes from Baijiayun participated in the event.
CaliberCos Inc. (Nasdaq: CWD) (“Caliber” or the "Company"), a real estate investor, developer, and asset manager, today announced the pricing of its underwritten public offering of total units for gross proceeds of approximately $900,000, prior to deducting underwriting discounts and commissions and offering expenses.
JUPITER, FL, April 18, 2025 (GLOBE NEWSWIRE) -- Safety Shot, Inc. (Nasdaq: SHOT) (the “Company” or “Safety Shot”), today announced that the record date for the spin-off and distribution of shares of common stock, par value $0.0001 per share, (“Caring Brands Common Stock”), of Caring Brands, Inc. (“CABR”), currently a subsidiary of the Company, has been postponed from the date set for April 7, 2025 (the “ Original Record Date”). Stockholders of the Company and holders of certain warrants issued in the Company’s public offering in July 2021 (the “Warrants”) will receive one share of Caring Brands ...
Ticker | Name | Price | Change | Change % | Market Cap | Volume |
---|---|---|---|---|---|---|
![]() | Bitcoin | 84,880.74 | 396.91 | 0.47% | 1.68T | 1,117,830,412 |
![]() | Ethereum | 1,596.93 | 8.00 | 0.50% | 192.23B | 583,801,719 |
![]() | Tether USD | 0.99987 | 0.00 | 0.00% | 141.91B | 97,536,895 |
![]() | Ripple | 2.08 | 0.020 | 0.97% | 120.15B | 371,839,770 |
![]() | Binance Coin | 592.14 | 0.075411 | 0.01% | 93.42B | 135,972,122 |
![]() | Solana | 138.37 | 4.18 | 3.11% | 67.33B | 593,150,761 |
![]() | USD Coin | 1.00 | 0.00007 | 0.01% | 56.1B | 598,091,868 |
![]() | Dogecoin | 0.15907 | 0.00146 | 0.93% | 23.52B | 127,747,802 |
![]() | Cardano | 0.632 | 0.0044 | 0.70% | 22.73B | 80,306,130 |
![]() | TRON | 0.241396 | 0.001578 | 0.66% | 20.78B | 133,473,936 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions